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Abstract
Background: As a key player in suppression of colon tumorigenesis, Adenomatous Polyposis Coli
(APC) has been widely studied to determine its cellular functions. However, inconsistencies of
commercially available APC antibodies have limited the exploration of APC function. APC is
implicated in spindle formation by direct interactions with tubulin and microtubule-binding protein
EB1. APC also interacts with the actin cytoskeleton to regulate cell polarity. Until now, interaction
of APC with the third cytoskeletal element, intermediate filaments, has remained unexamined.
Results: We generated an APC antibody (APC-M2 pAb) raised against the 15 amino acid repeat
region, and verified its reliability in applications including immunoprecipitation, immunoblotting, and
immunofluorescence in cultured cells and tissue. Utilizing this APC-M2 pAb, we
immunoprecipitated endogenous APC and its binding proteins from colon epithelial cells
expressing wild-type APC. Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS),
we identified 42 proteins in complex with APC, including β-catenin and intermediate filament (IF)
proteins lamin B1 and keratin 81. Association of lamin B1 with APC in cultured cells and human
colonic tissue was verified by co-immunoprecipitation and colocalization. APC also colocalized with
keratins and remained associated with IF proteins throughout a sequential extraction procedure.
Conclusion: We introduce a versatile APC antibody that is useful for cell/tissue immunostaining,
immunoblotting and immunoprecipitation. We also present evidence for interactions between
APC and IFs, independent of actin filaments and microtubules. Our results suggest that APC
associates with all three major components of the cytoskeleton, thus expanding potential roles for
APC in the regulation of cytoskeletal integrity.
Background
Mutation of Adenomatous Polyposis Coli (APC) is an
early event in colorectal carcinogenesis. The various sub-
cellular localizations and binding partners of APC impli-
cate this tumor suppressor in a wide variety of cellular
functions in normal cells. The most well characterized
function of APC is to inhibit Wnt-β-catenin signaling by
forming a multi-protein complex which targets cytoplas-
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regulation of cytoskeletal integrity has also been pro-
posed.
APC linkage with the actin network was demonstrated by
both direct interaction of APC with actin and by actin-
dependent membrane-localization of APC [4,5]. Ectopic
expression of APC, truncation of APC by mutation, and
APC loss all result in aberrant cell migration [6-8]. Identi-
fication of APC in a complex with IQGAP, a scaffolding
protein that binds to growing microtubules and regulates
actin filament elongation, provides evidence that APC
participates in cell migration [9,10]. Depletion of either
APC or IQGAP1 inhibits actin polymerization and cell
polarization [9]. APC also positively affects ASEF, a gua-
nine nucleotide exchange factor specific for Cdc42 [11-
13]. A truncated APC protein similar to those associated
with colon cancers was unable to activate ASEF [12]. APC
interaction with the microtubule cytoskeleton has also
been established. Early localization studies identified APC
at the plus ends of microtubules, implicating APC in cell
migration [14,15]. The functional interaction of APC with
the microtubule network is strengthened by the finding
that APC directly interacts with tubulin and the microtu-
bule-binding protein, EB1 [16-18]. Depletion of APC
destabilizes microtubules and inhibits spindle formation
and cellular protrusions, thereby compromising cellular
migration [19].
Actin-containing microfilaments, microtubules, and
intermediate filaments (IFs), constitute the three main
cytoskeletal elements that act coordinately to regulate cell
structure, polarity and migration. IFs function as a scaf-
fold to maintain cell and tissue integrity and defects in IF
impact a number of diseases (see review [20]). In the
present study, we provide further evidence for the involve-
ment of APC in the regulation of cytoskeletal structure
through interaction with IFs. Using purified polyclonal
sera raised against the 15 amino acid repeat region of APC
(referred to APC-M2 pAb), we identified interactions
between APC and IF proteins lamin B1, lamin B2, keratin
81 and keratin 82. We verified the lamin B1 interaction
with APC by co-immunoprecipitation as well as by
immunofluorescence microscopy in both cultured cells
and human colonic tissue. Nuclear lamins are type V IFs
that form a spherical mesh lining the nuclear envelope,
providing attachment sites for chromosomes and nuclear
pores [21]. The keratin/APC interaction was further sup-
ported by protein co-localization in cultured cells. Kerat-
ins are type I and II IFs that are predominantly found in
epithelial cells, providing structural integrity to those cells
so that they can withstand mechanical stress [22]. Identi-
fying an interaction between APC and IFs expands the
potential role of APC in cytoskeletal regulation. Although
APC expression and functions have been widely studied
in basic research and clinical settings, recent reports have
raised questions about the accuracy and reliability of
many commercially available antibodies [23,24]. There-
fore, an APC antibody that accurately determines levels
and subcellular localizations of APC in cells and espe-
cially in tissues is extremely important. Our characteriza-
tion of the APC-M2 pAb validates its use in a variety of
applications including detection of APC protein in mouse
and human tissues.
Results
Intermediate Filament protein lamin B1 co-precipitates 
with APC using the new APC-M2 pAb
As a multi-functional tumor suppressor protein, APC has
been widely analyzed regarding its subcellular localiza-
tion and its interaction with other proteins. Most com-
mercial antibodies, which were raised against either the
N- or C-terminus of APC, recognize proteins other than
APC [23,25]. This cross reactivity makes it difficult to
obtain reliable data using standard molecular and cellular
biology techniques to study APC. Thus, we injected rab-
bits with purified protein corresponding to the central
domain of APC (amino acids 959-1338, Additional File
1) and we affinity-purified sera from these rabbits
(referred to hereafter as APC-M2 pAb). Our initial analysis
of APC-M2 pAb in cultured cells utilized HCT116βw
colon epithelial cells that possess only the wild-type β-cat-
enin allele and thus differ from the parental HCT116 cells
that contain one wild-type and one mutant β-catenin
allele [26]. APC-M2 pAb recognizes full-length APC which
appears as a single band of ~310 kDa in lysates from
HCT116βw cells and truncated mutant APC (~150 kDa)
in lysates from SW480 cells (Figure 1A). No band was
detected in lysates from HCA46 cells which are essentially
null for APC [27]. Both full-length and truncated APC
were efficiently precipitated using APC-M2 pAb (Figure
1B). A well established binding partner of APC, β-catenin,
was also co-precipitated with full-length APC from
HCT116βw cell lysates (Figure 1B). Thus, we confirmed
the reliability of APC-M2 pAb for use in immunoblotting
and immunoprecipitation.
APC is a multi-functional protein involved in several dif-
ferent cellular pathways. Many of APC's functions are only
beginning to be elucidated. Identifying novel binding
partners for APC is a step toward fully understanding
APC's involvement in the maintenance of cellular integ-
rity. Therefore, APC-M2 pAb was used to co-immunopre-
cipitate APC and its associated proteins from HCT116βw
cell lysates. Nine protein bands that were unique to the
APC co-precipitation and not observed using preimmune
sera as a control were visualized by colloidal blue staining
(Additional file 2). These bands and corresponding
regions from the control lane were separately isolated,
pooled and analyzed by Liquid Chromatography TandemPage 2 of 13
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APC binding proteins that precipitated with APC antisera
and not with preimmune sera were identified as having
cross-correlation scores (x-corr) of 2 for 2+ ion and
2.5 for 3+ ion (Additional file 3). These 43 proteins
could be grouped in eight broad categories, the largest two
being cytoskeletal regulation and RNA processing/transla-
tion. From the most abundant potential APC-binding
proteins found, we chose to examine the interaction of
APC with intermediate filaments in more detail. IF pro-
teins identified were lamin B1, lamin B2, keratin 81 and
keratin 82 (Table 1). Initially, we focused on the most
abundantly APC-associated protein of the four, lamin B1.
Interaction of lamin B1 with APC was verified by co-
immunoprecipitation (Figure 1C).
Lamin B1 and keratin colocalization with APC revealed 
using APC-M2 pAb
To validate the interaction of lamin B1 with APC using
colocalization, we first verified the utility of APC-M2 pAb
for immunofluorescence microscopy. APC-M2 pAb recog-
nizes APC at cell-cell junctions, in the nucleus and in the
cytoplasm of U2OS cells (Figure 2A). This pattern showed
considerable overlap with that of one of the most fre-
quently utilized commercially available APC antibodies,
ali12-28, which was raised against amino acid 135-422.
Moreover, APC-M2 pAb effectively detected a truncated
APC protein expressed as a GFP-fusion in HCT116βw cells
(Figure 2B). Because the exogenous GFP-fused APC was
greatly over-expressed, the exposure time for the APC-M2
pAb signal was shortened to reveal the overlapping pat-
tern. In contrast, APC-M2 pAb did not recognize GFP
fused to the SV40 Nuclear Localization Signal (NLS).
To further validate the specificity of APC-M2 pAb, U2OS
cells were transfected with a plasmid containing GFP and
either a small hairpin RNA (shRNA) specific for APC or a
negative control shRNA. Thus, cells expressing the shRNA
plasmids can be identified by the presence of GFP. Cells
expressing the negative control shRNA plasmid displayed
no alteration in APC signal intensity using APC-M2-pAb
for immunofluorescence microscopy (Figure 3A). In con-
trast, cells expressing either of two APC-specific shRNA
Lamin B1 co-precipitates with endogenous APC using APC-M2 pAbFigure 
Lamin B1 co-precipitates with endogenous APC 
using APC-M2 pAb. (A) APC-M2 pAb specifically detects 
full-length (~310 kDa) APC in HCT116βw cell lysates and 
truncated (~150 kDa) APC in SW480 cell lysates by immu-
noblot. APC-M2 pAb does not detect APC in HCA46 cell 
lysates, null for APC. Equivalent total protein (30 μg) was 
resolved in each lane. Blot shows entire spectrum of proteins 
from > 300 kDa to ~15 kDa. α-tubulin is shown as a loading 
control. (B) APC-M2 pAb immunoprecipitates APC from 
HCT116βw (left panel) and SW480 (right panel) cell lysates. 
β-catenin co-precipitates with full-length APC (left panel, 
middle blot). Neither APC nor β-catenin co-precipitated 
with preimmunue sera (Preim). P, precipitated proteins from 
270 μg protein lysates; S, 10% of non-precipitated superna-
tant proteins (27 μg). Input, 5% of total input proteins (25 
μg). (C) Endogenous lamin B1 co-precipitated with APC 
using APC-M2 pAb, but not preimmune sera. Precipitated 
proteins from 376 μg protein lysates were loaded. Input, 6% 
of total input proteins (37.5 μg). The lower band in the APC 
IP lane represents degradation products.
Table 1: Intermediate filament proteins associated with APC as 
identified using LC-MS/MS
Protein Accession No Peptides found 1st/2nd run
Lamin B1 Q6DC98 7/6
Lamin B2 Q03252 2/3
Keratin 81 Q14533 5/5
Keratin 82 Q9NSB4 2/2
(at least 2 peptides found in each duplicate run; all peptides passed 
Xcorr cutoffs of 2 for +2 ion and 2.5 for +3 ion)Page 3 of 13
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mic and nuclear APC signal intensity (Figure 3A). As
another critical negative control, APC-M2 pAb did not
reveal immunofluorescence signal above background in
HCA46 cells which do not express APC (Figure 3B). The
slight fluorescent signal seen in HCA46 cells stained using
APC-M2 pAb or in HCT116βw cells stained using purified
rabbit IgG (Figure 3B) was similar to that of control cells
stained with only secondary antibody (Additional file 4).
Having validated APC-M2 pAb for use in immunofluores-
cence applications, we probed HCT116βw cells for endog-
enous APC and IF proteins lamin B1 and keratin. In single
confocal slices, APC appeared in puncta that partially
overlapped lamin B1 and aligned with some keratin fila-
ments (data not shown). Figure 4A shows APC and either
keratin or laminB1 signals each captured in 20 z-plane
images and projected into a single image. Because the APC
signal did not completely coincide with that of keratin or
laminB1, quantitation of the overlap was performed by
determining the Pearson's correlation coefficient from
~700 individual confocal images representing >65 indi-
vidual cells captured in three-dimensions (Figure 4B).
Correlation coefficients of APC/lamin B1 and APC/kera-
tin pairs were significantly higher than that of negative
control samples stained with only the secondary antibod-
ies (Figure 4B and Additional file 4C). On average, 11% of
the APC signal overlapped that of keratin and 27% over-
lapped that of lamin B1 (Figure 4B). In Figure 4C, images
were analyzed for random overlap by shifting the green
and red signals by 20 pixels in the x-direction. Offset in
either direction resulted in a decrease in the correlation,
indicating that the overlap is not a chance occurrence
from two relatively abundant signals (Figure 4C, 1st and
3rd panels). In addition, the cross-correlation coefficient
APC-M2 pAb recognizes endogenous and exogenous APC protein by immunofluorescence microscopyFigure 2
APC-M2 pAb recognizes endogenous and exogenous 
APC protein by immunofluorescence microscopy. (A) 
U2OS cells double-labeled with APC-M2 pAb (red) and com-
mercial anti-APC (ali12-28) mAb (green). (b) Magnified image 
of a region indicated in (a) shows considerable overlap of red 
and green signals. Scale bars, 5 μm. (B) Colocalization of 
APC1417 fused-GFP (green, upper panel) or NLS (nuclear 
localization signal from SV40) fused-GFP tag (green, lower 
panel) with APC-M2 pAb (red) signal. Short exposure 
revealed APC-M2 pAb signal overlapping that of GFP-
APC1417. Longer (normal) exposure led to saturated signal in 
GFP-APC1417-expressing cells but allowed visualization of 
endogenous APC staining with APC-M2 pAb in adjacent non-
transfected HCT116βw cells. Note that there is no overlap 
of APC-M2 pAb labeling with NLS fused GFP signal. Scale 
bar, 5 μm.
APC-M2 pAb immunofluorescence signal reduced by APC-shRNAFigure 3
APC-M2 pAb immunofluorescence signal reduced by 
APC-shRNA. (A) U2OS cells transfected for 48 hours with 
negative control shRNA or one of two individual shRNA 
plasmids specific for APC were probed using APC-M2 pAb. 
GFP (green) expression from the shRNA vector marks trans-
fected cells. Expression of either shRNA-APC number 5 or 6 
resulted in reduction of the majority of the nuclear and cyto-
plasmic APC-M2 pAb signal. Scale bar, 5 μm. (B) Immunoflu-
orescence microscopy using APC-M2 pAb to probe HCA46 
cells, null for APC (upper panel), or purified rabbit IgG to 
probe HCT116βw cells (lower panel) reveals only minimal 
signal. Scale bars, 5 μm.Page 4 of 13
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IF proteins lamin B1 and keratins colocalize with endogenous and exogenous APC in cultured cellsFigure 4
IF proteins lamin B1 and keratins colocalize with endogenous and exogenous APC in cultured cells. (A) Confocal 
immunofluorescence microscopy reveals partial overlap of APC (red) and keratin (green) or lamin B1 (green) in HCT116βw 
cells. Single projections of 20 images resolved along the z-axes for lamin and 30 images for keratin are shown. Scale bar, 4.6 
μm. (B) More than 700 individual images were analyzed for each protein pair examined to determine the Pearson's correlation 
coefficient (upper graph) or the Manders overlap coefficient (lower graph). Additional file 4B shows representative image of 
the negative control (both secondary antibodies with no primary antibody). The average Pearson's correlation coefficient ± 
SEM calculated from n individual z-series images (n = 900, keratin/APC; n = 720, lamin B1/APC) were significantly higher than 
the correlation coefficient determined for the negative control (* and ** p < 0.0001). (C) The Van Steeples cross correlation 
function (CCF) was plotted as a function of image offset in pixels. Keratin and lamin B1 each show a peak of correlation with 
the APC signal in the original position with no offset (dx, red line). In contrast, the CCF is low, with multiple peaks for keratin 
or lamin B1 with a randomized APC signal. (D) HCT116βw cells expressing full-length APC fused to GFP were stained for ker-
atin or lamin B1 (red). Confocal images show partial overlap of the keratin and lamin B1 signals with GFP. Scale bars, 5 μm.
BMC Cell Biology 2009, 10:75 http://www.biomedcentral.com/1471-2121/10/75for keratin or lamin B with a randomized APC signal was
low and showed multiple peaks (Figure 4C, 2nd and 4th
panels). Results from the image analysis validated the
observed co-localization of APC with both lamin B and
keratin. As an alternative approach to further investigate
this co-localization, full length APC was expressed as a
GFP fusion. In single confocal slices, the GFP signal dis-
played partial overlap with both keratin and lamin B1
(Figure 4D). Taken together, the observed cellular co-
localization is consistent with an association between
APC and IF proteins keratin and lamin B1.
Lamin B1 colocalization with APC in human colonic tissue 
revealed using APC-M2 pAb
In normal human colon tissue, APC-M2 pAb predomi-
nantly marked the cell junctions, with increasing cytoplas-
mic and nuclear expression in epithelial cells at the
luminal surface (Figure 5A-a). Lamin B1 showed perinu-
clear expression in epithelial cells in the upper half of the
crypts and also in mesenchymal cells located between
crypts. Both APC and lamin B1 exhibited increasing
expression from the crypt base toward the luminal surface
(Figure 5A-a). A higher magnification of the confocal
image reveals perinuclear colocalization of APC with
lamin B1 at the luminal surface (Figure 5A-b). A similar
co-localization could be seen further down the crypt
where the APC signal was not as saturated (Figure 5A-c).
Unlike lamin B1 staining, APC staining appeared more
intense in epithelial cells than in surrounding stromal
cells. As a positive control, normal human colonic tissue
was co-stained for β-catenin and APC (Figure 5B). APC-
M2 pAb revealed APC in both nuclei and at cell junctions,
with a staining pattern partially overlapping that of β-cat-
enin. Human colon tissue stained with rabbit preimmune
sera and purified mouse IgG revealed only minimal signal
and provided a negative control (Figure 5C).
APC association with intermediate filament proteins is not 
dependent on actin or tubulin
IFs interact with both actin-containing microfilaments
and microtubules (see review [28]). Because APC also
associates with actin and microtubules, it is possible that
the co-immunoprecipitation of IF proteins with APC is
due to precipitation of a large complex of cytoskeletal
components. To determine whether the APC/IF interac-
tion was dependent on actin-containing microfilaments
and microtubules, we performed a traditional solubiliza-
tion and extraction of both tubulin- and actin-containing
microfilament proteins from cells, leaving behind pre-
dominantly insoluble IFs and desmosomes [29]. After
sequential extraction, the cytoskeletal proteins tubulin
and actin were efficiently removed from cells as deter-
mined by immunofluorescence microscopy (Figure 6A).
APC, however, remained cell-associated, as did IF proteins
lamin B1 and keratin. Colocalization of APC with keratins
was apparent in extracted cells, with the APC appearing as
puncta along the keratin filaments (Figure 6B). That APC
remains cell-associated following this extraction proce-
dure suggests a stable interaction between APC and IFs,
independent of actin-containing microfilaments and
microtubules.
APC-M2 pAb is a versatile antibody, specific for APC
We have demonstrated specificity of APC-M2 pAb for APC
protein by immunoblot (Figure 1A), immunoprecipita-
tion (Figure 1B-C and Additional file 3) and immunoflu-
orescence confocal microscopy using both cultured cells
and human tissue (Figure 2, 3, and 5). Many mouse mod-
els have been established to analyze APC functions in the
context of a whole mammalian organism. To validate the
use of APC-M2 pAb in animal studies, frozen sections of
mouse small intestinal tissue were probed with APC-M2-
pAb and then APC was visualized using confocal micros-
copy. The staining of APC was most intense in cells at the
top of villi, with less APC in cells near the crypt base (Fig-
ure 7A). APC appeared at cell-cell junctions and in the
cytoplasm with occasional nuclear localization (Figure 7).
In the villus, cytoplasmic puncta were also visible, partic-
ularly near the basal surface (Figure 7B). Of note, APC-M2
pAb did not reveal the apical APC distribution in intesti-
nal tissues which was previously attributed to cross reac-
tivity with a non-APC protein [23].
Discussion
In the current study, we have generated purified polyclo-
nal antiserum that is specific for APC. APC-M2 pAb is ver-
satile and can be used to detect APC in immunostaining,
immunoblotting and immunoprecipitation. Using this
antibody, we identified a novel interaction between APC
and IFs. The APC and IF protein interactions were con-
firmed by co-precipitation and colocalization using both
endogenous and GFP-tagged exogenous APC in cultured
epithelial cells. Association of APC with IFs is not depend-
ent on actin-containing microfilaments and microtu-
bules.
APC mutations are found in over 80% of all colorectal
cancers and have been assessed for screening and progno-
sis purposes in the clinical setting. For such research,
access to an APC antibody that accurately depicts levels
and subcellular localizations of APC in cells and espe-
cially in tissues is extremely important. According to
Wakeman et. al. [23], many commercially available anti-
bodies also recognize an unidentified protein that local-
izes to the apical region of polarized epithelial cells. Most
currently available commercial APC antibodies were
raised against several hundred amino acids at either the N-
or C-terminus of the APC protein. However, most of these
antibodies have not been proven to be specific for APC
[23]. Furthermore, many of these antibodies are only use-Page 6 of 13
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APC colocalizes with lamin B1 in human colonic tissueFigure 5
APC colocalizes with lamin B1 in human colonic tissue. (A) Confocal immunofluorescence microscopy of cryosections 
from normal human colon tissues triple-labeled with APC-M2 pAb (green), anti-lamin B1 (red) and DNA dye topro-3 (blue). 
Arrows point to stromal cells in which lamin B1 staining is more intense compared to adjacent epithelial cells within crypts. In 
contrast, less APC staining is detected in stromal cells compared to crypt epithelial cells. Tissues are oriented such that luminal 
surfaces are at the top of the images. (b) and (c) Enlarged images of two regions indicated in (a). (B) APC colocalizes with β-
catenin in the cytoplasm and cell junctions of human colonic crypts. (b) Enlarged image of a region at the base a colonic crypt 
shown in (a). (C) Immunofluorescence microscopy using preimmune sera and purified mouse IgG to probe consecutive tissue 
sections revealed only minimal signal. Scale bars, 20 μm.
BMC Cell Biology 2009, 10:75 http://www.biomedcentral.com/1471-2121/10/75ful for a single application. For example, anti-APC Ab-7 is
only effective when used for immunostaining. Therefore,
we generated a new antibody against the 15 amino acid
repeat region in the middle of APC (Additional file 1). The
affinity-purified APC-M2 pAb recognizes junctional, cyto-
plasmic and nuclear APC by immunostaining (Figure 2A)
without producing the non-specific apical staining pattern
previously seen [23]. Although there was a great deal of
overlap, immunofluorescent signals from APC-M2 pAb
and anti-APC ali12-28 were not 100% coincident. The
ali12-28 antibody was raised against a different portion of
APC protein than M2-APC. The most likely explanation
for the slight signal disparity is that the epitopes recog-
nized by APC-M2 pAb are masked by APC folding, or the
binding of another protein to a subset of the APC protein.
In a similar manner, it would be expected that the epitope
recognized by ali12-28 might be inaccessible in some frac-
tion of the APC protein.
One of the most clinically relevant applications for APC
antibodies is for immunohistochemical analysis of tis-
sues. We have validated the use of APC-M2 pAb for immu-
nostaining sections of frozen human colonic tissue and
mouse small intestinal tissues. Previously, APC has been
detected in both the nucleus and cytoplasm of human
colonic tissue, with more prevalent cytoplasmic staining
in colonic tumors compared to normal tissue [30]. In our
study of human colon tissue, APC-M2 pAb revealed APC
in both nuclei and at cell-cell junctions, partially colocal-
ized with β-catenin, similar to previous reports [14,30]
(Figure 5B). APC protein also appeared concentrated near
the basal surface of epithelial cells (Figure 5A and 5B) as
previously reported [31]. APC staining became most
intense in cells at the top of villi in the mouse small intes-
tine (Figure 7A-B) and in cells at the luminal surface of the
human colon (Figure 5A), consistent with a role for APC
in differentiated cells. Most importantly, APC-M2 pAb did
not recognize protein at the apical surface of intestinal tis-
sues. Thus, APC-M2 pAb does not appear to exhibit the
cross reactivity previously reported for some commer-
cially available APC antibodies [23]. Taken together, the
APC-M2 pAb is a useful antibody for future examination
APC remains associated with IF proteins following extraction of actin and tubulinFigu 6
APC remains associated with IF proteins following 
extraction of actin and tubulin. (A) Left two panels, 
184A1 epithelial cells analyzed by immunofluorescence 
microscopy reveal distribution of APC, lamin B1, keratin, 
tubulin, actin (detected with phalloidin) and DNA (blue in 
DIC overlay). Right two panels, following sequential extrac-
tion, APC remained cell associated, along with IF proteins 
lamin B1 and keratin. Note that actin, tubulin, and DNA 
were successfully extracted from these cells. Nuclei are indi-
cated by DAPI staining. (B) Colocalization of APC (green) 
with keratins (red) after cell extraction. Scale bars, 10 μm.
APC-M2 pAb recognizes endogenous APC protein in normal mouse intestinal tissueFig re 7
APC-M2 pAb recognizes endogenous APC protein in 
normal mouse intestinal tissue. Confocal immunofluo-
rescence microscopy of cryosections from wild-type mouse 
ileum triple-labeled with APC-M2 pAb (green), β-catenin 
mAb (red) and DNA dye topro-3 (blue). Tissues are oriented 
so that luminal surfaces are at the top of the images. (A) An 
increasing gradient of APC staining from crypts to villus tips 
is apparent at this magnification. (B) Enlarged image of a 
region at the villus tip shown in (A). APC staining is concen-
trated in basolateral regions of villus epithelial cells. Scale 
bars, 20 μm.Page 8 of 13
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BMC Cell Biology 2009, 10:75 http://www.biomedcentral.com/1471-2121/10/75of APC in mouse and human tissue sections. At present,
APC-M2 pAb does not appear to recognize APC in forma-
lin-fixed paraffin-embedded tissues (data not shown).
Intermediate filaments are essential components of
cytoskeletal structure. Recent reports have implicated APC
in the regulation of cellular structural integrity through
affects on microtubule growth directionality and polarity
[32,33]. APC also associates with microtubule-interacting
protein EB1, and actin-associated protein ASEF [11,18].
Our own previous screen for APC-interacting proteins
identified keratin 18 (Stecklein and Neufeld, personal
communication). Although classified as a hair cuticle-spe-
cific keratin, keratin 81 is expressed in a wide variety of tis-
sues including mammary gland and lung and in human
embryonic kidney 293T cells [34-37]. Keratin 82 is also
thought to be expressed predominantly in hair and nail.
However, when flag-tag specific antibodies were used to
immunoprecipitate flag-tagged human homolog 3 of
Drosophila Disc-large (hDlg) from human embryonic
kidney 293 cells, keratin 82 was identified as a protein
partner [38]. This observation is significant because it
indicates that keratin 82 has a broader expression pattern
than initially suggested and because hDlg protein itself is
a binding partner of APC [39].
Downregulation of β-catenin activity by APC is not lim-
ited to the cytoplasmic destruction complex. Association
of APC with β-catenin in the nucleus appears to result in
sequestration of β-catenin from the TCF/LEF transcription
factor leading to inactivation of Wnt-responsive genes
[40]. Furthermore, chromatin immunoprecipitation anal-
ysis revealed that APC associated with the enhancer region
of a Wnt-responsive gene in a similar temporal manner as
several co-repressors, suggesting that APC can oppose a
Wnt signal by associating with co-repressors at the tran-
scription complex [41]. Given the emerging role of the
nuclear lamina in gene regulation [42], it is tempting to
speculate that APC association with lamin B1 is yet
another mechanism by which expression of Wnt-respon-
sive genes is regulated. Moreover, finding APC associated
with the nucleus after extraction suggests APC might be
bound to the nuclear matrix. This observation is consist-
ent with our previous finding that the majority of nuclear
APC purified with the nuclear matrix [43].
As a vital part of the cytoskeleton, intermediate filaments
are dynamic and can stabilize cellular organelles such as
the nucleus [44]. Mutations in genes encoding IF proteins
are associated with a number of diseases such as Moni-
lethrix (K81) [45], Autosomal dominant leukodystrophy
(LMNB1) [46], acquired partial lipodystrophy (LMNB2)
[47], and various other lipodystrophies and cardiomyopa-
thies [20]. APC potentially cross-links IFs to improve their
stability or binds IFs to other structures such as actin fila-
ments or microtubules. Therefore, truncated APC found
in the majority of colorectal cancers and also in other can-
cers, might have a compromised ability to link APC bind-
ing partners with different IF proteins. It is worth noting
that full-length APC has been found near IFs in epithelial
cells from human colon tissue using immunogold elec-
tron microscopy [48]. Given the evidence for an associa-
tion of APC with IFs, it is predicted that disruption of IFs
would result in APC redistribution. Our attempts to dis-
rupt IFs by treating cells with acrylamide led to cell shrink-
ing, but not elimination of IFs (data not shown). Further
study of this novel APC/IF interaction using a related
approach might illuminate the underlying mechanisms of
intermediate filament protein-associated diseases.
Conclusion
In summary, we identified an interaction between APC
and intermediate filament proteins lamin B1 and keratin
using a novel antibody, APC-M2 pAb. The APC-M2 pAb
antibody is specific for APC, versatile, and reliable, with
potential value in the clinical setting and in translational
research. By sequential extraction of cytoskeletal compo-
nents, we have shown that the association of APC with IF
proteins is not dependent on actin and tubulin. Finding
APC associated with IF proteins confirms and expands
upon the previous notion that APC is in close association
with the cytoskeleton, raising the possibility that APC
functions in the maintenance of cytoskeletal structure and
integrity.
Methods
Cell culture, transfection, and tissue preparation
HCT116βw (a generous gift from Bert Vogelstein) and
U2OS cells (ATCC) were grown in McCoy's 5A media
(Gibco) supplemented with 10% Fetal bovine serum
(FBS) (Hyclone). SW480 cells (ATCC) were grown in
RPMI 1640 media (Cellgro) supplemented with 10% FBS.
HCA46 cells (a generous gift from Ian Tomlinson) were
grown in high glucose DMEM media (Gibco) supple-
mented with 10% FBS. 184A1 cells (a generous gift from
Martha Stampfer) are immortalized human mammary
epithelial cells [49], and were grown in MCDB 170 media
(Clonetics) supplemented as described [50]. Lipo-
fectamine 2000 (Invitrogen) was used to transfect cells
with various GFP fusion expression constructs and SureSi-
lencing shRNA plasmids specific for APC (shRNA-5 and
shRNA-6) or non-specific as a negative control (SABio-
sciences). Colon and ileum tissues were removed from an
8-week old male C57/BL6 mouse (Charles Rivers Labora-
tory) immediately after CO2 asphyxiation, rolled into
"Swiss rolls", embedded in OCT medium (Sakura Fine-
tek) and frozen in ethanol-dry ice. Fresh normal human
colonic tissue was immediately embedded in OCT
medium and frozen in ethanol-dry ice.Page 9 of 13
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Tissue cryosections or cultured cells were fixed in 4% para-
formaldehyde in PBS. Immunostaining of fixed tissue cry-
osections and cultured cells was performed as described
[43,51,52]. Briefly, post-fixation samples were incubated
with blocking buffer (5% normal goat serum, 1% bovine
serum albumin and 0.1% triton X-100) for one hour at
room temperature. Samples were then incubated with pri-
mary antibodies diluted in the blocking buffer at 4°C
overnight, followed by 3 washes in PBS for 10 minutes
each. Finally, samples were stained with secondary anti-
bodies diluted in blocking buffer for 30 minutes followed
by 3 washes in PBS. To better preserve IF structures, cells
were incubated at -20°C for 20 minutes in 100% EtOH
following the fixation step. Coverslips were mounted on
slides with Prolong Antifade (Invitrogen). Antibodies
used for immunostaining include APC-M2 pAb (1;1000),
anti-APC (1:20, ali12-28, Calbiochem), anti-β-catenin
(1:200, Transduction Lab), anti-lamin B1 (1:50, Calbio-
chem), anti-pan-keratin (1:50, Biomeda), Rhodamine-
phalloidin (1:500, Invitrogen), and a cocktail of mAbs
against anti-α&β-tubulin (a generous gift from Dave
Gard); secondary antibodies used were goat anti-mouse
IgG FITC (1:200, Molecular Probes), goat anti-mouse IgG
Alexa 488 (1:1000, Molecular Probes), goat anti-rabbit
IgG Alexa 568 (1:500, Molecular Probes), and goat anti-
mouse IgG Alexa 568 (1:500, Molecular Probes). DNA
was labeled with Topro-3 (1:1000, Molecular Probes) or
DAPI (1:1000, Molecular Probes). Negative controls
included incubation with secondary antibody alone, or
replacing primary antibodies with purified IgG/preim-
mune sera, or secondary antibody with primary antibody
of opposing species (e.g. Alexa 488 anti-mouse IgG with
APC-M2-pAb, Additional file 4). These negative controls
resulted in only minimal signal.
Immunostained cells or tissues were visualized using a
PlanNeofluor 40X/1.3 oil objective on a Carl Zeiss Laser
Scanning Microscope (LSM) 510. Images were analyzed
using Zeiss LSM Image Browser Version 4.2. Images of
human colon sections were captured as 2(X) by 3(Y) sub-
images and automatically reassembled as one montage
image.
Protein colocalization analysis
For three dimensional analyses of immunofluorescent sig-
nals, images were captured using a Yokugawa-type spin-
ning disk confocal microscope equipped with an
Olympus 100× objective (Olympus and Intelligent Imag-
ing Innovations, Denver, CO). For each protein pair ana-
lyzed, >65 cells were randomly selected to be imaged.
Twenty to thirty image frames were collected at z-intervals
of 100 nm for each cell. Raw confocal image series were
analyzed by ImageJ program (NIH, Bethesda, MD) and
the JACoP plugin without further processing [53]. Colo-
calization coefficients were calculated using Pearson's cor-
relation coefficient or Manders' coefficient as described
[51] and were plotted as mean ± SEM using GraphPad
Prism software. For calculation of Van Steensel's cross-cor-
relation function (CCF), raw confocal images from multi-
ple z-planes were analyzed by JACoP plugin. APC images
were subjected to 200 rounds of pixel randomization to
generate randomized APC images to use as negative con-
trols for the CCF.
Immunoprecipitation and immunoblots
Purified recombinant His-S-M2-APC was resolved on a 4-
12% NUPAGE gel (Invitrogen) and stained using a Colloi-
dal Blue Staining Kit (Invitrogen) according to manufac-
turer's protocol. Immunoprecipitation (IP) and
immunoblots (IB) were performed using modified stand-
ard protocols. Cells at 90% confluency were lysed in
buffer containing 50 mM Tris (pH 7.5), 0.1% NP-40, 100
mM NaCl, 1 mM MgCl2, 5 mM EDTA, protease inhibitor
cocktail (Sigma) and Halt phosphatase inhibitor cocktail
(PIERCE) on ice for 30 minutes. Cell lysates were soni-
cated for 10 pulses at level 1 with 10% output 3 times
using an ultrasonic homogenizer (Branson Sonifier 450).
Soluble lysates were obtained by centrifugation at 17,000
× g for 20 minutes at 4°C. Specific antibodies were first
pre-incubated with Protein-A dynabeads (Invitrogen) for
2 hours at room temperature. Then antibody saturated
dynabeads were washed with 0.2 M triethanolamine (pH
8.0) twice and crosslinked using 4 mM DMP (PIERCE) in
0.2 M triethanolamine (pH 8.0) for 15 minutes.
Crosslinking was stopped by adding 1/10 volume of 1 M
Tris (pH 8.0) and incubating for 2 hours. For each reac-
tion, 1 ug of antibody crosslinked to dynabeads was
added to 1 mg of soluble lysate and incubated overnight
at 4°C. Immunoprecipitated proteins were subject to two
washes of 15 minutes using lysis buffer and two washes
using PBS-T at 4°C. Immunoblots were probed with: puri-
fied anti-APC-M2 (1:5000), anti-lamin B1 (Oncogene,
1:1000), anti-β-catenin (Sigma, 1:2000), and anti-α-tubu-
lin (Oncogene, 1:2000).
Proteomic analysis
Proteins co-precipitated with purified APC-M2 antibody
or preimmune sera were resolved on a 4-12% NUPAGE
gel (Invitrogen) and stained using a Colloidal Blue Stain-
ing Kit (Invitrogen) according to manufacturer's protocol.
The nine gel regions from each sample indicated in "Addi-
tional file 2" were excised and combined into experimen-
tal and negative control samples respectively. These were
then equilibrated in 50 mM NH4HCO3, reduced with 3
mM DTT in 100 mM NH4HCO3 at 37°C for 15 minutes,
and alkylated with 6 mM iodoacetamide in 50 mM
NH4HCO3 for 15 minutes. The gel pieces were then dehy-
drated with acetonitrile and rehydrated with 15 μl of 12.5
mM NH4HCO3containing 0.01 μg/μl Modified TrypsinPage 10 of 13
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hours at 37°C. Peptides were extracted with 60% ace-
tonitrile/0.1% formic acid, dried by vacuum centrifuga-
tion and reconstituted in 30 μl of 0.1% formic acid. Each
peptide hydrosylate (5 μl) was analyzed by C18 reverse-
phase LC-MS/MS using a Thermo LTQ Ion Trap Mass
Spectrometer equipped with a Thermo MicroAS Autosam-
pler and Thermo Surveyor HPLC Pump, nanospray
source, and Xcalibur 1.4 instrument control essentially as
described [54]. Tandem MS data were collected from inde-
pendent duplicate experiments, and analyzed with the
Sequest algorithm to search the unihuman2 database (Jan
23 2007, 223514 entries) using Xcorr cutoffs of 2 for
[M+2H]2+/2 ions and 2.5 for [M+3H]3+/3 ions [55]. In
addition, the database contained a concatenated reverse
decoy database to estimate false-discovery rates, which
were 5% or below. Proteins identified from negative con-
trol samples were subtracted from the experimental sam-
ples. Only proteins that appeared in both duplicate
experiments were displayed in Table 1 and Additional file
3.
Sequential extraction of cytoskeletal elements
The protocol for sequential extraction of cells was adapted
from protocols previously described [29]. Briefly, cells
were sequentially incubated with cytoskeletal buffer [10
mM PIPES pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM
MgCl2, 1 mM EGTA and 0.5% Triton X-100] and extrac-
tion buffer [10 mM PIPES, 250 mM ammonium sulfate,
300 mM sucrose, 3 mM MgCl2, and 1 mM EGTA] on ice
for 5 minutes, digestion buffer [210 mM PIPES pH 6.8,
300 mM sucrose, 50 mM NaCl, 3 mM MgCl2, 1 mM
EGTA, 2 μl/ml DNase and 125 μl/ml RNase I] at 20°C for
20 minutes, and 2 M NaCl in PBS on ice for 5 minutes.
Finally, cells were fixed with 4% paraformaldehyde in PBS
and subjected to immunostaining.
DNA constructs, recombinant proteins and fusion protein 
purification
To generate recombinant N-terminal His and S dual-tag
fused APC fragment M2, the corresponding cDNA for APC
(amino acid 1000-1326) was amplified using PCR and
subcloned into a pET-30a(+) vector. The DNA construct
encoding GST-fused M2-APC (amino acid 959-1338) was
a generous gift from Kozo Kaibuchi. Both His-S-M2-APC
and GST-M2-APC fusion proteins were expressed and
purified as described [51,56]. Expression constructs for
GFP fused with full length APC, APC1417 or NLS were gen-
erated by PCR amplification of the corresponding regions
and insertion into pGFP-C1 vector (Clonetch).
Affinity-purification of anti-APC-M2 antibody
Anti-APC-M2 rabbit serum was generated by injecting
purified S-tag fused M2-APC as the antigen. Serum was
acquired and applied to a column of GST-fused M2-APC
covalently linked to NHS-Sepharose FastFlow (GE health-
care) according to manufacturer's protocol. After washing
with Phosphate Buffered Saline (PBS) plus 0.1% Tween-
20 (PBS-T) to remove non-specific proteins, bound anti-
bodies were eluted from the antigen column with 0.2 M
Glycine (pH 2.0). Eluted antibodies were dialyzed with
PBS containing 10% Glycerol and concentrated to 1 mg/
ml using a centrifugal concentrator. Affinity-purified anti-
body was stored at 4°C with preservatives and is referred
to as APC-M2 pAb.
List of abbreviations
APC: Adenomatous Polyposis Coli; IF: intermediate fila-
ment; LC-MS/MS: Liquid Chromatography Tandem Mass
Spectrometry; pAb: polyclonal antibody
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Generation of recombinant M2-APC immunogen. (A) Schematic dia-
gram of the N-terminal His and S dual-tag fused APC fragment (amino 
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20 amino acid repeat. (B) Purified recombinant M2-APC protein (~50 
kDa) used for immunization was resolved by SDS-PAGE and detected 
using colloidal blue.
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APC-M2 pAb co-precipitates APC binding proteins. Proteins co-precip-
itated from HCT116 w cell lysates using APC-M2 pAb were resolved on a 
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9 protein bands that were precipitated using the APC-M2 pAb and not 
using preimmune sera.
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